From Antilymphocyte Serum to Therapeutic Monoclonal Antibodies: First Experiences with a Chimeric CD4 Antibody in the Treatment of Autoimmune Disease
- 1 October 1992
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 129 (1) , 81-104
- https://doi.org/10.1111/j.1600-065x.1992.tb01420.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effects of isotype and Fc region on in vitro function of a mouse/human chimeric CD4 antibodyInternational Immunology, 1993
- Signal for T-cell differentiation to a CD4 cell lineage is delivered by CD4 transmembrane region and/or cytoplasmic tailNature, 1992
- Enhanced expression of HLA-class II molecules on activated human T lymphocytes following treatment with tumor necrosis factor alphaHuman Immunology, 1991
- Autoimmunity, microbial immunity and the immunological homunculusImmunology Today, 1991
- Anti-CD4 monoclonal antibody administration in renal transplanted patientsClinical Immunology and Immunopathology, 1990
- Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cellsJournal of Autoimmunity, 1989
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Manipulation Of T-Cell Responses With Monoclonal AntibodiesAnnual Review of Immunology, 1989
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- THE USE OF SPECIFIC "LYMPHOCYTE" ANTISERA TO INHIBIT HYPERSENSITIVE REACTIONS OF THE "DELAYED" TYPEThe Journal of Experimental Medicine, 1961